1.
Med. clín (Ed. impr.)
; 160(12): 566-566, jun. 2023. ilus
Article
Es
| IBECS
| ID: ibc-221829
2.
Med Clin (Barc)
; 160(12): 566, 2023 06 23.
Article
En, Es
| MEDLINE
| ID: mdl-36774290
3.
Rheumatology (Oxford)
; 61(10): e326-e327, 2022 10 06.
Article
En
| MEDLINE
| ID: mdl-35298625
4.
Pediatr Dermatol
; 39(3): 478-480, 2022 May.
Article
En
| MEDLINE
| ID: mdl-35178751
The association of multiple pilomatricomas with xeroderma pigmentosum has not been described. We report a case of a child with multiple pilomatricomas and photosensitivity who was found to have a pathogenic variant in exon 4 of XPA and a likely pathogenic variant in COL6A1.
Hair Diseases , Pilomatrixoma , Skin Neoplasms , Xeroderma Pigmentosum , Child , Hair Diseases/complications , Humans , Pilomatrixoma/complications , Skin Neoplasms/complications , Xeroderma Pigmentosum/complications , Xeroderma Pigmentosum Group A Protein
5.
Dermatol Ther
; 35(3): e15258, 2022 03.
Article
En
| MEDLINE
| ID: mdl-34890096
6.
J Dtsch Dermatol Ges
; 18(4): 378-380, 2020 Apr.
Article
En
| MEDLINE
| ID: mdl-32291914
Antineoplastic Agents/therapeutic use , Hypereosinophilic Syndrome/drug therapy , Imatinib Mesylate/therapeutic use , Leukemia/drug therapy , Lymphomatoid Papulosis/drug therapy , Skin Neoplasms/drug therapy , Humans , Male , Middle Aged , Protein Kinase Inhibitors/therapeutic use , Treatment Outcome
7.
8.
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 37(10): 673-674, dic. 2019. ilus
Article
Es
| IBECS
| ID: ibc-189596
No disponible
Humans , Female , Adult , Dermatomycoses/diagnosis , Dermatomycoses/microbiology , Granuloma/diagnosis , Granuloma/microbiology , Dermatomycoses/drug therapy , Granuloma/drug therapy , Fluconazole/therapeutic use , Terbinafine/therapeutic use , Antifungal Agents/administration & dosage , Edema/diagnosis , Trichophyton/isolation & purification
9.
Enferm Infecc Microbiol Clin (Engl Ed)
; 37(10): 673-674, 2019 Dec.
Article
En, Es
| MEDLINE
| ID: mdl-31060866
10.
Med. clín (Ed. impr.)
; 149(3): e15-e15, ago. 2017. ilus
Article
Es
| IBECS
| ID: ibc-164972
11.
Am J Dermatopathol
; 39(5): e60-e61, 2017 May.
Article
En
| MEDLINE
| ID: mdl-28426490
Antifungal Agents/administration & dosage , Graft vs Host Disease/pathology , Mucormycosis/drug therapy , Opportunistic Infections/drug therapy , Opportunistic Infections/pathology , Acute Disease , Biopsy, Needle , Drug Therapy, Combination , Epidermis/pathology , Graft vs Host Disease/diagnosis , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/methods , Humans , Immunocompromised Host , Immunohistochemistry , Male , Middle Aged , Mucormycosis/immunology , Mucormycosis/pathology , Necrosis/pathology , Opportunistic Infections/diagnosis , Prognosis , Risk Assessment
12.
Am J Dermatopathol
; 39(5): 369, 2017 May.
Article
En
| MEDLINE
| ID: mdl-26909588
Antifungal Agents/administration & dosage , Graft vs Host Disease/pathology , Immunocompromised Host , Mucormycosis/drug therapy , Mucormycosis/pathology , Acute Disease , Biopsy, Needle , Graft vs Host Disease/immunology , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/methods , Humans , Immunohistochemistry , Male , Middle Aged , Mucormycosis/immunology , Necrosis/pathology , Prognosis , Risk Assessment
13.
Med Clin (Barc)
; 149(3): e15, 2017 08 10.
Article
En, Es
| MEDLINE
| ID: mdl-27916265
14.
Med. clín (Ed. impr.)
; 141(8): 366-367, oct. 2013.
Article
Es
| IBECS
| ID: ibc-116312
15.
Med Clin (Barc)
; 141(8): 366-7, 2013 Oct 19.
Article
Es
| MEDLINE
| ID: mdl-23540382